Worcester Foundation for Experimental Biology

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
 
 
C07K PEPTIDES 3133
 
 
 
C07H SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS 297
 
 
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 1254
 
 
 
C12Q MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS 1124

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

  • No Recent Publications to Display

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
5824776 Cell-targeted lytic pore-forming agentsDec 05, 96Oct 20, 98[A61K, C07K]
5817771 Cell-targeted lytic pore-forming agentsDec 27, 94Oct 06, 98[C07K]
5777078 Triggered pore-forming agentsJun 07, 95Jul 07, 98[C07K]
5563253 Linear aminoalkylphosphoramidate oligonucleotide derivativesMar 03, 94Oct 08, 96[C07H, C12Q]
5321131 Site-specific functionalization of oligodeoxynucleotides for non-radioactive labellingMar 08, 90Jun 14, 94[C07H]

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
5789187 Identification of differentiation factor receptors which inhibit the tumorigenicity of neuroblastoma cells in a ligand-independent mannerExpiredSep 21, 94Aug 04, 98[A61K, C12Q, C12N]
5387520 Treatment of tumor cells in vitro with neurotrophic factors and cell proliferation inhibitorsExpiredAug 27, 92Feb 07, 95[A61K, C07H]
5109126 5'[2'(3')-O-(2,4,6-trinitrophenyl) pyprimidine nucleoside]diphosphate 1-glycosidesExpiredDec 06, 88Apr 28, 92[C07H]
5049550 Diadenosine 5', 5'"-p.sup.1, p.sup.4,-tetraphosphate analogs as antithrombotic agentsExpiredNov 21, 88Sep 17, 91[A61K, C07H]

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.